Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
15(44%)
Results Posted
20%(2 trials)
Terminated
1(3%)

Phase Distribution

Ph not_applicable
15
44%
Ph phase_2
1
3%
Ph phase_4
1
3%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution17 total trials
Phase 2Efficacy & side effects
1(5.9%)
Phase 4Post-market surveillance
1(5.9%)
N/ANon-phased studies
15(88.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

15

trials recruiting

Total Trials

34

all time

Status Distribution
Active(17)
Completed(10)
Terminated(1)
Other(6)

Detailed Status

Recruiting13
Completed10
unknown6
Active, not recruiting2
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
34
Active
15
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (5.9%)
Phase 41 (5.9%)
N/A15 (88.2%)

Trials by Status

active_not_recruiting26%
terminated13%
completed1029%
not_yet_recruiting26%
unknown618%
recruiting1338%

Recent Activity

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more
NCT07450196

A Prospective, Multicenter, Observational Study Evaluating Safety and Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Replacement for Type-0 Bicuspid Aortic Valve Stenosis Patients in China

Not Yet Recruiting
NCT05171712Not Applicable

Portico and Navitor India Clinical Trial

Completed
NCT07413965Not Applicable

TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

Not Yet Recruiting
NCT06472934Not Applicable

Impact of Beta-blocker on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement (B-TAVR)

Recruiting
NCT07148973

Outcomes for Patients With Ascending Aortic Dilation Who Underwent TAVR

Completed
NCT06924151Not Applicable

Isolated Surgical Aortic Valve Replacement in Low Risk AS Patients

Recruiting
NCT07145463Not Applicable

Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions

Recruiting
NCT02791880

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

Active Not Recruiting
NCT05607667Not Applicable

Clinical Trial in China for Aortic Valve Stenosis

Completed
NCT05002088

Portico Valve-in-Valve Retrospective Registry

Completed
NCT03876964

J-Valve Compassionate Use

Unknown
NCT05739253

Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement

Recruiting
NCT04982406

Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System

Completed
NCT06743568Not Applicable

Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation

Recruiting
NCT06589063

Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis

Recruiting
NCT06381271

Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation

Recruiting
NCT06379386

Long-term Prognosis and Valve Durability of TAVR

Recruiting
NCT06257043

Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese Patients

Recruiting
NCT02825134Not Applicable

Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis

Active Not Recruiting
NCT06136429Not Applicable

A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis

Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
34